01 1Active Pharma Inc.
02 1Aurobindo Pharma Limited
03 1DNP Fine Chemicals Utsunomiya Co., Ltd.
04 1Daiwa Pharmaceutical Industries Co., Ltd.
05 1Eli Lilly Kinsale Limited
06 1HETERO DRUGS LIMITED.
07 1JUBILANT PHARMOVA LIMITED
08 1JW Pharmaceutical Corporation
09 1Jiangsu Hansoh Pharmaceutical Group Co. , Ltd.
10 1Permakem Asia Co., Ltd.
11 1Shiratori Pharmaceutical Co., Ltd.
12 1Tateyama Chemical Co., Ltd.
13 2Tokuyama Corporation
14 1Yoshindo Co., Ltd.
01 11Olanzapine
02 1Olanzapine "Lily"
03 1Olanzapine "Tateyama"
04 1Olanzapine (production only)
05 1Olanzapine production dedicated
01 1China
02 3India
03 9Japan
04 1U.S.A
05 1Blank
Registration Number : 227MF10030
Registrant's Address : 2477, Nambusunhwan-ro Seocho-gu, Seoul, Republic of Korea
Initial Date of Registration : 2015-01-23
Latest Date of Registration : 2015-11-11
Registration Number : 227MF10066
Registrant's Address : 1062-8 Honjo, Nishikata-cho, Tochigi City, Tochigi Prefecture
Initial Date of Registration : 2015-03-06
Latest Date of Registration : 2015-11-11
Registration Number : 227MF10065
Registrant's Address : 7-2-A2, Hetero Corporate, Industrial Estates, Sanath Nagar, Hyderabad-500 018, Telang...
Initial Date of Registration : 2015-03-06
Latest Date of Registration : 2015-11-19
Registration Number : 227MF10037
Registrant's Address : 1A, Sector 16A, Noida 201 301, Uttar Pradesh, India
Initial Date of Registration : 2015-02-04
Latest Date of Registration : 2015-02-04
Registration Number : 227MF10016
Registrant's Address : 1-10-11, Nihonbashi Horidomecho, Chuo-ku, Tokyo
Initial Date of Registration : 2015-01-05
Latest Date of Registration : 2015-11-17
Registration Number : 227MF10025
Registrant's Address : 2-36-1 Kanda Jinbocho, Chiyoda-ku, Tokyo
Initial Date of Registration : 2015-01-23
Latest Date of Registration : 2015-11-17
Olanzapine (for manufacturing purposes only)
Registration Number : 226MF10142
Registrant's Address : 2-3-5 Shimookui, Toyama City, Toyama Prefecture
Initial Date of Registration : 2014-07-31
Latest Date of Registration : 2015-05-14
Registration Number : 227MF10046
Registrant's Address : 6-11-24 Tsudanuma, Narashino City, Chiba Prefecture
Initial Date of Registration : 2015-02-09
Latest Date of Registration : 2015-11-11
Registration Number : 226MF10039
Registrant's Address : 1133 Oe, Imizu City, Toyama Prefecture
Initial Date of Registration : 2014-02-19
Latest Date of Registration : 2015-11-17
Registration Number : 226MF10220
Registrant's Address : 3697-8 Hagishima, Funauchi-cho, Toyama City, Toyama Prefecture
Initial Date of Registration : 2014-11-17
Latest Date of Registration : 2015-11-12
A Olanzapine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Olanzapine, including repackagers and relabelers. The FDA regulates Olanzapine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Olanzapine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Olanzapine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Olanzapine supplier is an individual or a company that provides Olanzapine active pharmaceutical ingredient (API) or Olanzapine finished formulations upon request. The Olanzapine suppliers may include Olanzapine API manufacturers, exporters, distributors and traders.
click here to find a list of Olanzapine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Olanzapine Drug Master File in Japan (Olanzapine JDMF) empowers Olanzapine API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Olanzapine JDMF during the approval evaluation for pharmaceutical products. At the time of Olanzapine JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Olanzapine suppliers with JDMF on PharmaCompass.
We have 14 companies offering Olanzapine
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?